These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8970990)

  • 1. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle.
    Reicin AS; Ohagen A; Yin L; Hoglund S; Goff SP
    J Virol; 1996 Dec; 70(12):8645-52. PubMed ID: 8970990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
    Reicin AS; Paik S; Berkowitz RD; Luban J; Lowy I; Goff SP
    J Virol; 1995 Feb; 69(2):642-50. PubMed ID: 7815527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.
    Wiegers K; Rutter G; Kottler H; Tessmer U; Hohenberg H; Kräusslich HG
    J Virol; 1998 Apr; 72(4):2846-54. PubMed ID: 9525604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
    Berthoux L; Péchoux C; Ottmann M; Morel G; Darlix JL
    J Virol; 1997 Sep; 71(9):6973-81. PubMed ID: 9261426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
    Accola MA; Höglund S; Göttlinger HG
    J Virol; 1998 Mar; 72(3):2072-8. PubMed ID: 9499062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.
    Koma T; Kotani O; Miyakawa K; Ryo A; Yokoyama M; Doi N; Adachi A; Sato H; Nomaguchi M
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.
    Mammano F; Ohagen A; Höglund S; Göttlinger HG
    J Virol; 1994 Aug; 68(8):4927-36. PubMed ID: 8035491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.
    Wang CT; Lai HY; Li JJ
    J Virol; 1998 Oct; 72(10):7950-9. PubMed ID: 9733833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
    Joshi A; Nagashima K; Freed EO
    J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.
    Kiernan RE; Ono A; Freed EO
    J Virol; 1999 Jun; 73(6):4728-37. PubMed ID: 10233933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
    Shehu-Xhilaga M; Hill M; Marshall JA; Kappes J; Crowe SM; Mak J
    J Virol; 2002 May; 76(9):4331-40. PubMed ID: 11932399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro processing of human immunodeficiency virus type 1 Gag virus-like particles.
    Morikawa Y; Shibuya M; Goto T; Sano K
    Virology; 2000 Jul; 272(2):366-74. PubMed ID: 10873780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of two zinc finger motifs in HIV type 1 nucleocapsid proteins: effects on proteolytic processing of Gag precursors and particle formation.
    Mizuno A; Ido E; Goto T; Kuwata T; Nakai M; Hayami M
    AIDS Res Hum Retroviruses; 1996 Jun; 12(9):793-800. PubMed ID: 8738431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
    Kiernan RE; Ono A; Englund G; Freed EO
    J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.
    Scheifele LZ; Kenney SP; Cairns TM; Craven RC; Parent LJ
    J Virol; 2007 Oct; 81(19):10718-28. PubMed ID: 17634229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.
    Ott DE; Coren LV; Chertova EN; Gagliardi TD; Nagashima K; Sowder RC; Poon DT; Gorelick RJ
    J Virol; 2003 May; 77(10):5547-56. PubMed ID: 12719547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional surfaces of the human immunodeficiency virus type 1 capsid protein.
    von Schwedler UK; Stray KM; Garrus JE; Sundquist WI
    J Virol; 2003 May; 77(9):5439-50. PubMed ID: 12692245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
    J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.